发明名称 CRYSTALLINE SOLID FORMS OF N-{4-[(6,7-DIMETHOXYQUINOLIN-4-YL)OXY]PHENYL}-N'-(4-FLUOROPHENYL) CYCLOPROPANE-1,1-DICARBOXAMIDE, PROCESSES FOR MAKING, AND METHODS OF USE
摘要 The invention relates to novel crystalline solid forms of the chemical compound N- {4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl } -N'-(4-fluorophenyl) cyclopropane-1,1- dicarboxamide (Compound 1), and solvates thereof, including hydrates, that are useful for the treatment of cancer. Also disclosed are pharmaceutical compositions comprising the crystalline solid forms and processes for making the crystalline solid forms, as well as methods of using them for the treatment of cancer, particularly thyroid cancer, prostate cancer, hepatocellular cancer, renal cancer, and non-small cell lung carcinoma. The crystalline solid forms can be used to make the L-malate salt of cabozantinib.
申请公布号 CA2939546(A1) 申请公布日期 2015.08.20
申请号 CA20152939546 申请日期 2015.02.16
申请人 EXELIXIS, INC. 发明人 AFTAB, DANA T.;GUZ, NATHAN;LAU, STEPHEN;HAMILL, NOEL;WALKER, TRACY;GALBRAITH, JANA;YAU, SIMON;SHAH, KHALID
分类号 C07D215/22;A61K31/47;A61P35/00 主分类号 C07D215/22
代理机构 代理人
主权项
地址